Abstract
Tremendous interest in the dopamine D4 receptor subtype was generated when it became clear that the atypical antipsychotic drug clozapine binds to it with particularly high affinity. These data, along with the distribution of the D4 receptor in the brain, suggested that a selective D4 receptor antagonist was a suitable target for new antipsychotic drug development. In fact, a novel D4 receptor …
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
